Just months after a federal judge approved a U.S. Justice Department settlement in November finalizing CVS Health Corp.’s nearly $70 billion acquisition of Aetna Inc. over the antitrust concerns of some medical and consumer groups, the health care giant is facing the biggest public health crisis the United States and arguably the world has faced in decades: the global COVID-19 pandemic.
Thomas Moriarty, the Woonsocket, Rhode Island, company’s top lawyer, is guiding CVS through the thicket of complex legal and regulatory issues the company now faces from the worldwide spread of the novel coronavirus, which is not only taking a big toll in lives but also disrupting business operations and supply chains of medical equipment and drugs on several continents.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]